These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 2477197)
1. Mechanism of activation of complexed pp60c-src by the middle T antigen of polyomavirus. Cheng SH; Harvey R; Piwnica-Worms H; Espino PC; Roberts TM; Smith AE Curr Top Microbiol Immunol; 1989; 144():109-20. PubMed ID: 2477197 [No Abstract] [Full Text] [Related]
2. The carboxy terminus of pp60c-src is a regulatory domain and is involved in complex formation with the middle-T antigen of polyomavirus. Cheng SH; Piwnica-Worms H; Harvey RW; Roberts TM; Smith AE Mol Cell Biol; 1988 Apr; 8(4):1736-47. PubMed ID: 2454396 [TBL] [Abstract][Full Text] [Related]
3. Simultaneous overexpression of avian pp60c-src and polyomavirus middle T antigen in mammalian cells. Cook DN; Pavloff N; Hassell JA J Virol; 1990 May; 64(5):2392-5. PubMed ID: 2157894 [TBL] [Abstract][Full Text] [Related]
4. Transformation by polyoma virus middle T antigen. Courtneidge SA Cancer Surv; 1986; 5(2):173-82. PubMed ID: 2430702 [TBL] [Abstract][Full Text] [Related]
5. Stimulation of pp60c-src kinase activity in FDC-P1 cells by polyoma middle-T antigen and hematopoietic growth factors. Muser J; Kaech S; Moroni C; Ballmer-Hofer K Oncogene; 1989 Dec; 4(12):1433-9. PubMed ID: 2480561 [TBL] [Abstract][Full Text] [Related]
6. An 81 kd protein complexed with middle T antigen and pp60c-src: a possible phosphatidylinositol kinase. Courtneidge SA; Heber A Cell; 1987 Sep; 50(7):1031-7. PubMed ID: 2441879 [TBL] [Abstract][Full Text] [Related]
7. Further characterisation of the complex containing middle T antigen and pp60. Courtneidge SA Curr Top Microbiol Immunol; 1989; 144():121-8. PubMed ID: 2477198 [No Abstract] [Full Text] [Related]
8. Peptide antibodies to the human c-fyn gene product demonstrate pp59c-fyn is capable of complex formation with the middle-T antigen of polyomavirus. Cheng SH; Harvey R; Espino PC; Semba K; Yamamoto T; Toyoshima K; Smith AE EMBO J; 1988 Dec; 7(12):3845-55. PubMed ID: 2463167 [TBL] [Abstract][Full Text] [Related]
9. Induction of tumor formation and cell transformation by polyoma middle T antigen in the absence of Src. Thomas JE; Aguzzi A; Soriano P; Wagner EF; Brugge JS Oncogene; 1993 Sep; 8(9):2521-9. PubMed ID: 7689725 [TBL] [Abstract][Full Text] [Related]
10. Analysis of polyomavirus middle-T-antigen-transformed rat cell variants expressing different levels of pp60c-src. Bolen JB; Amini S; DeSeau V; Reddy S; Shalloway D J Virol; 1987 Apr; 61(4):1079-85. PubMed ID: 2434664 [TBL] [Abstract][Full Text] [Related]
11. Association of p62c-yes with polyomavirus middle T-antigen mutants correlates with transforming ability. Kornbluth S; Cheng SH; Markland W; Fukui Y; Hanafusa H J Virol; 1990 Apr; 64(4):1584-9. PubMed ID: 1690822 [TBL] [Abstract][Full Text] [Related]
12. Regulation of pp60c-src and its interaction with polyomavirus middle T antigen in insect cells. Piwnica-Worms H; Williams NG; Cheng SH; Roberts TM J Virol; 1990 Jan; 64(1):61-8. PubMed ID: 2152834 [TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of the hamster polyomavirus middle T antigen. Courtneidge SA; Goutebroze L; Cartwright A; Heber A; Scherneck S; Feunteun J J Virol; 1991 Jun; 65(6):3301-8. PubMed ID: 1709702 [TBL] [Abstract][Full Text] [Related]
14. Analysis of middle tumor antigen and pp60c-src interactions in polyomavirus-transformed rat cells. Bolen JB; DeSeau V; O'Shaughnessy J; Amini S J Virol; 1987 Oct; 61(10):3299-305. PubMed ID: 2442413 [TBL] [Abstract][Full Text] [Related]
15. Mutation of a cysteine residue in polyomavirus middle T antigen abolishes interactions with protein phosphatase 2A, pp60c-src, and phosphatidylinositol-3 kinase, activation of c-fos expression, and cellular transformation. Glenn GM; Eckhart W J Virol; 1993 Apr; 67(4):1945-52. PubMed ID: 7680388 [TBL] [Abstract][Full Text] [Related]
16. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells. Kamps MP; Sefton BM Oncogene Res; 1988 Sep; 3(2):105-15. PubMed ID: 2465525 [TBL] [Abstract][Full Text] [Related]
17. Characterization of two 85 kd proteins that associate with receptor tyrosine kinases, middle-T/pp60c-src complexes, and PI3-kinase. Otsu M; Hiles I; Gout I; Fry MJ; Ruiz-Larrea F; Panayotou G; Thompson A; Dhand R; Hsuan J; Totty N Cell; 1991 Apr; 65(1):91-104. PubMed ID: 1707345 [TBL] [Abstract][Full Text] [Related]
18. Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice. Guy CT; Muthuswamy SK; Cardiff RD; Soriano P; Muller WJ Genes Dev; 1994 Jan; 8(1):23-32. PubMed ID: 7507074 [TBL] [Abstract][Full Text] [Related]
19. Transformation of NIH 3T3 cells by cotransfection with c-src and nuclear oncogenes. Shalloway D; Johnson PJ; Freed EO; Coulter D; Flood WA Mol Cell Biol; 1987 Oct; 7(10):3582-90. PubMed ID: 2446117 [TBL] [Abstract][Full Text] [Related]
20. Avian pp60c-src is more active when expressed in yeast than in vertebrate fibroblasts. Cooper JA; Runge K Oncogene Res; 1987; 1(4):297-310. PubMed ID: 2453017 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]